tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Hypercalcemia D006934 13 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Takada Y et al. Improvement of allograft viability with organs procured from non-heart-beating donors in porcine liver transplantation. 2000 Transplant. Proc. pmid:10715416
Morita H et al. Acceptance of skin xenografts (from guinea pig to mice) by portal venous and intravenous injections of donor hematolymphoid cells. 2000 Transplant. Proc. pmid:10715422
Vela CG et al. Prospective study of lipid disorders in FK506-versus cyclosporine-treated renal transplant patients. 2000 Transplant. Proc. pmid:10715453
Dunnett SB The failure of axon regeneration in the CNS is not absolute. 1999 Neuroreport pmid:10716198
Sugawara T et al. Immunosuppressants promote adult dorsal root regeneration into the spinal cord. 1999 Neuroreport pmid:10716239
Campbell G et al. Spontaneous axonal regeneration after optic nerve injury in adult rat. 1999 Neuroreport pmid:10716240
Smythe GM et al. Enhanced migration and fusion of donor myoblasts in dystrophic and normal host muscle. 2000 Muscle Nerve pmid:10716768
Lee M et al. FK506 promotes functional recovery in crushed rat sciatic nerve. 2000 Muscle Nerve pmid:10716776
Carr DB et al. Maternal hemodynamics and pregnancy outcome in women with prior orthotopic liver transplantation. 2000 Liver Transpl. pmid:10719023
Hale GA et al. Blood tacrolimus concentrations in bone marrow transplant patients undergoing plasmapheresis. 2000 Bone Marrow Transplant. pmid:10723590
Inomata Y et al. [Weaning of immunosuppression in living-related liver transplantation]. 1999 Nihon Rinsho Meneki Gakkai Kaishi pmid:10726480
Konrad T et al. Evidence for impaired glucose effectiveness in cirrhotic patients after liver transplantation. 2000 Metab. Clin. Exp. pmid:10726916
Fukuda H et al. Differences between lymphocyte subsets, after allogeneic bone marrow transplantation, in patients who received tacrolimus and patients who received cyclosporin A. 2000 Int. J. Hematol. pmid:10729997
Plosker GL and Foster RH Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation. 2000 Drugs pmid:10730553
Bargalló N et al. Cortical laminar necrosis caused by immunosuppressive therapy and chemotherapy. 2000 AJNR Am J Neuroradiol pmid:10730638
Ierardi E et al. Oral tacrolimus (FK 506) in Crohn's disease complicated by fistulae of the perineum. 2000 J. Clin. Gastroenterol. pmid:10730928
Sigalet DL et al. Impact of FK506 and steroids on adaptation after intestinal resection or segmental transplantation. 2000 Pediatr Transplant pmid:10731053
Pappas PA et al. Sirolimus in pediatric gastrointestinal transplantation: the use of sirolimus for pediatric transplant patients with tacrolimus-related cardiomyopathy. 2000 Pediatr Transplant pmid:10731058
Eades SK et al. Increased tacrolimus levels in a pediatric renal transplant patient attributed to chronic diarrhea. 2000 Pediatr Transplant pmid:10731062
Squadrito F et al. Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia- reperfusion injury. 2000 J. Mol. Cell. Cardiol. pmid:10731442
Prima V et al. Alteration of the glucocorticoid receptor subcellular localization by non steroidal compounds. 2000 Jan-Feb J. Steroid Biochem. Mol. Biol. pmid:10731632
Adalsteinsson H and Bruice TC Generation and evaluation of putative neuroregenerative drugs. Part 1: virtual point mutations to the polyketide rapamycin. 2000 Bioorg. Med. Chem. pmid:10732978
Kawai T et al. FK506-induced autoimmune diabetes. 2000 Ann. Intern. Med. pmid:10733461
Wong KM et al. Abbreviated tacrolimus area-under-the-curve monitoring for renal transplant recipients. 2000 Am. J. Kidney Dis. pmid:10739787
Böhmig GA et al. Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graft. 2000 Am. J. Kidney Dis. pmid:10739788
Li ST et al. High Ca(2+)/low Mg(2+) solution induces long-term depression in rat CA1 pyramidal neurons. 2000 Neurosci. Lett. pmid:10739895
Dubowchik GM et al. Fluoresceinated FKBP12 ligands for a high-throughput fluorescence polarization assay. 2000 Bioorg. Med. Chem. Lett. pmid:10741553
Weidelt T and Isenberg G Augmentation of SR Ca(2+) release by rapamycin and FK506 causes K(+)-channel activation and membrane hyperpolarization in bladder smooth muscle. 2000 Br. J. Pharmacol. pmid:10742283
Yoshida EM et al. Post-transplant diabetic ketoacidosis--a possible consequence of immunosuppression with calcineurin inhibiting agents: a case series. 2000 Transpl. Int. pmid:10743693
Emre S et al. Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients. 2000 Transpl. Int. pmid:10743694
Skuk D et al. Myoblast transplantation in whole muscle of nonhuman primates. 2000 J. Neuropathol. Exp. Neurol. pmid:10744058
Gaziev D et al. Chronic graft-versus-host disease: is there an alternative to the conventional treatment? 2000 Bone Marrow Transplant. pmid:10745252
Minematsu T et al. Pharmacokinetic/pharmacodynamic analysis of tacrolimus-induced QT prolongation in guinea pigs. 1999 Biol. Pharm. Bull. pmid:10746167
Chiou WL et al. Apparent lack of effect of P-glycoprotein on the gastrointestinal absorption of a substrate, tacrolimus, in normal mice. 2000 Pharm. Res. pmid:10751036
Shimizu T et al. Clinical and histological analysis of acute tacrolimus (TAC) nephrotoxicity in renal allografts. 1999 Clin Transplant pmid:10751057
Wang MS and Gold BG FK506 increases the regeneration of spinal cord axons in a predegenerated peripheral nerve autograft. 1999 J Spinal Cord Med pmid:10751133
Davis DL et al. Biochemical characterization of the minor immunophilins. 2000 Clin. Biochem. pmid:10751584
Freeman EE and Grosskreutz CL The effects of FK506 on retinal ganglion cells after optic nerve crush. 2000 Invest. Ophthalmol. Vis. Sci. pmid:10752948
Harmon JD et al. Stuttering priapism in a liver transplant patient with toxic levels of fk506. 1999 Urology pmid:10754131
Johnson C et al. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. 2000 Transplantation pmid:10755536
Miller J et al. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group. 2000 Transplantation pmid:10755543
Mohamed MA et al. TGF-beta expression in renal transplant biopsies: a comparative study between cyclosporin-A and tacrolimus. 2000 Transplantation pmid:10755567
Kano S et al. [Role of FK506-binding protein (FKBP) in Ca+ oscillation in bronchial epithelial cells]. 2000 Jpn J Antibiot pmid:10756444
Takahashi N [Macrolide compounds as inhibitors of the intracellular signal transmission pathway: the mechanism of actions of rapamycin and FK506]. 2000 Jpn J Antibiot pmid:10756454
Yamamoto K et al. Immune response to adenovirus-delivered antigens upregulates utrophin and results in mitigation of muscle pathology in mdx mice. 2000 Hum. Gene Ther. pmid:10757347
Minervini MI et al. Acute renal allograft rejection with severe tubulitis (Banff 1997 grade IB). 2000 Am. J. Surg. Pathol. pmid:10757402
Tchah H and Lim B Effect of FK 506 on the cornea: use of topical FK 506 in corneal transplantation in a guinea pig-rat model. 1999 Korean J Ophthalmol pmid:10761401
Thorp M et al. The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol. 2000 Transplantation pmid:10762229
Nevins TE Overview of new immunosuppressive therapies. 2000 Curr. Opin. Pediatr. pmid:10763765
Gordjani N et al. Cyclosporin-A-induced effects on the free Ca2+ concentration in LLC-PK1-cells and their mechanisms. 2000 Pflugers Arch. pmid:10764223
Brazis PW et al. A case of bilateral optic neuropathy in a patient on tacrolimus (FK506) therapy after liver transplantation. 2000 Am. J. Ophthalmol. pmid:10764869
Klein BC et al. Influence of mycophenolic acid and FK-506 on human platelet activation in vitro. 2000 Kidney Blood Press. Res. pmid:10765114
Fernández-Miranda C et al. Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy: effect of treatment with folic acid. 2000 Clin Transplant pmid:10770414
Outeda Macías M et al. Tacrolimus-itraconazole interaction in a kidney transplant patient. 2000 Ann Pharmacother pmid:10772445
pmid:10773614
Kraiss LW et al. Fluid flow activates a regulator of translation, p70/p85 S6 kinase, in human endothelial cells. 2000 Am. J. Physiol. Heart Circ. Physiol. pmid:10775131
Yamani MH et al. Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejection. 2000 J. Heart Lung Transplant. pmid:10775813
Attur MG et al. Differential anti-inflammatory effects of immunosuppressive drugs: cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production. 2000 Inflamm. Res. pmid:10778917
Peters D et al. Potentiation of CD3-induced expression of the linker for activation of T cells (LAT) by the calcineurin inhibitors cyclosporin A and FK506. 2000 Blood pmid:10779414
Chini EN and Walker H FK506 (tacrolimus) increases halothane-induced Ca2+ release from skeletal muscle sarcoplasmic reticulum. 2000 Anesthesiology pmid:10781282
Vestergaard C et al. The NC/Nga mouse: a model for atopic dermatitis. 2000 Mol Med Today pmid:10782068
Gonin JM Maintenance immunosuppression: new agents and persistent dilemmas. 2000 Adv Ren Replace Ther pmid:10782729
Kataoka T and Nagai K Involvement of FK506-sensitive and insensitive granule exocytosis pathways in perforin-dependent target cell lysis mediated by a CD8+ CTL clone. 2000 Immunol. Lett. pmid:10789681
Katayama Y et al. [Studies on brain pyruvate dehydrogenase (PDH) activity and energy metabolites during ischemia and reperfusion]. 1999 Rinsho Shinkeigaku pmid:10791103
Neckermann G et al. Atopic dermatitis-like symptoms in hypomagnesaemic hairless rats are prevented and inhibited by systemic or topical SDZ ASM 981. 2000 Br. J. Dermatol. pmid:10792216
Ramsay HM and Harden PN Cyclosporin-induced flushing in a renal transplant recipient resolving after substitution with tacrolimus. 2000 Br. J. Dermatol. pmid:10792253
Yoshizawa K et al. Time-specific occurrence of alopecia in neonatal C57BL mice treated with N-methyl-N-nitrosourea and the therapeutic efficacy of tacrolimus hydrate. 2000 Pathol. Int. pmid:10792780
Kiani A et al. Manipulating immune responses with immunosuppressive agents that target NFAT. 2000 Immunity pmid:10795734
Gaweco AS et al. Intragraft localization of activated nuclear factor kappaB in recurrent hepatitis C virus disease following liver transplantation. 2000 Hepatology pmid:10796896
Lu YM et al. Calcineurin-mediated LTD of GABAergic inhibition underlies the increased excitability of CA1 neurons associated with LTP. 2000 Neuron pmid:10798404
Qi S et al. Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey. 2000 Transplantation pmid:10798741
Borger P et al. Cyclosporine, FK506, mycophenolate mofetil, and prednisolone differentially modulate cytokine gene expression in human airway-derived epithelial cells. 2000 Transplantation pmid:10798763
Moffatt SD et al. STAT 6 up-regulation by FK506 in the presence of interleukin-4. 2000 Transplantation pmid:10798785
Adachi S et al. Successive expression and activation of NFAT family members during thymocyte differentiation. 2000 J. Biol. Chem. pmid:10799559
Biggar SR and Crabtree GR Chemically regulated transcription factors reveal the persistence of repressor-resistant transcription after disrupting activator function. 2000 J. Biol. Chem. pmid:10801867
Pirsch J et al. Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: pharmacokinetics and tolerability. 2000 J Clin Pharmacol pmid:10806606
Riley L et al. Cross-sensitivity reaction between tacrolimus and macrolide antibiotics. 2000 Bone Marrow Transplant. pmid:10808214
Chen XJ et al. Positive and negative control of multidrug resistance by the Sit4 protein phosphatase in Kluyveromyces lactis. 2000 J. Biol. Chem. pmid:10809730
Glanemann M et al. Higher immunosuppressive efficacy of mycophenolate mofetil in combination with FK 506 than in combination with cyclosporine A. 2000 Transplant. Proc. pmid:10812095
White SA et al. Randomized trial comparing neoral and tacrolimus immunousuppression for recipients of renal transplants procured from different donor groups. 2000 Transplant. Proc. pmid:10812132
Taber DJ et al. Drug-drug interaction between chloramphenicol and tacrolimus in a liver transplant recipient. 2000 Transplant. Proc. pmid:10812156
Soran A et al. Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression. 2000 Transplant. Proc. pmid:10812157
McLaughlin GE et al. Use of phenobarbital in the management of acute tacrolimus toxicity: a case report. 2000 Transplant. Proc. pmid:10812158
Levy GA Neoral use in the liver transplant recipient. 2000 Transplant. Proc. pmid:10814745
Przepiorka D et al. Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1. 2000 Biol. Blood Marrow Transplant. pmid:10816027
Küsters E et al. Purification of an ascomycin derivative with simulated moving bed chromatography. A case study. 2000 J Chromatogr A pmid:10817355
Wang JJ et al. Dimerization-dependent block of the proapoptotic effect of p75(NTR). 2000 J. Neurosci. Res. pmid:10820429
Ortega-Pérez I and Redondo JM [The NFAT transcription factor family as immunosuppression target]. 2000 Nefrologia pmid:10822734
Bang H et al. Prolyl isomerases in a minimal cell. Catalysis of protein folding by trigger factor from Mycoplasma genitalium. 2000 Eur. J. Biochem. pmid:10824113
Otley CC and Pittelkow MR Skin cancer in liver transplant recipients. 2000 Liver Transpl. pmid:10827224
Eckhoff DE et al. The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients. 2000 Transplantation pmid:10830224
Nakata Y et al. Tacrolimus and myocardial hypertrophy. 2000 Transplantation pmid:10830241
Blaheta RA et al. Mycophenolate mofetil decreases endothelial prostaglandin E2 in response to allogeneic T cells or cytokines. 2000 Transplantation pmid:10830246
Jindal RM and Dubernard JM Towards a specific immunosuppression for pancreas and islet grafts. 2000 Clin Transplant pmid:10831083
Rerolle JP et al. Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation. 2000 Clin Transplant pmid:10831087
Filler G et al. Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients. 2000 Nephrol. Dial. Transplant. pmid:10831643
Gallagher H et al. Post-transplantation lymphoproliferative disorder: an unusual presentation in a patient receiving tacrolimus. 2000 Nephrol. Dial. Transplant. pmid:10831670
Chen H et al. Compromised kidney graft rejection response in Vervet monkeys after withdrawal of immunosuppressants tacrolimus and sirolimus. 2000 Transplantation pmid:10836361
Moffatt SD and Metcalfe SM Comparison between tacrolimus and cyclosporine as immunosuppressive agents compatible with tolerance induction by CD4/CD8 blockade. 2000 Transplantation pmid:10836388
Higgins RM et al. Conversion from tacrolimus to cyclosporine in stable renal transplant patients: safety, metabolic changes, and pharmacokinetic comparison. 2000 Transplantation pmid:10836393